Skip to main content

Table 3 Use and non-adherence to ART among participants enrolled in the PMTCT study in Kyangwali Refugee camp, Western Uganda, May 2022 (N = 380)

From: Use and non-adherence to antiretroviral therapy among Refugee HIV positive pregnant mothers aged 18–49 years in Kyangwali refugee camp, Western Uganda

Variable

Measure

Outcome variable

Currently taking ART (Yes), n (%; 95%CI)

375 (98.7 ) [97.5–99.8]

Adhered to ART in the last one month (Yes), n (%; 95%CI)

276 (72.6) [68.1–77.1]

Didn’t adhere to ART in the last one month

104 (27.4) [22.9–31.9]

Intended to deliver at health facility

377 (99.2)

Plan to continue on ART/ PMTCT services in the future (Yes), n (%)

375 (98.7)

Other variables on PMTCT and HIV transmission

Heard of PMTCT services (Yes), n (%)

355 (93.4)

Believed that HIV can be transmitted from mother to baby during pregnancy (Yes), n (%)

320 (84.2)

Believed that HIV can be transmitted from mother to baby during delivery (Yes), n (%)

351 (92.4)

Believed that HIV can be transmitted from mother to baby during breastfeeding (Yes), n (%)

353 (93.0)

Believed that an HIV pregnant mother can still look health: (Yes), n (%)

319 (84.0)

Believed that every pregnant mother should be screened for HIV (Yes), n (%)

371 (97.6)

Believed that every HIV positive pregnant woman should be on ART (Yes), n (%)

371 (97.6)

  1. ART: Antiretroviral Therapy, PMTCT: Prevention of Mother to Child Transmission